Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsCareSource drug list update Coverage & Prior Auth …
    Ask Trek AI about this page
    CurrentCareSourcePolicy N/A

    HAP CareSource MI Coordinated Health List of Covered Drugs (Drug List)

    Customize your policy alerts

    Sign up for all CareSource policy alerts

    Know when CareSource releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document is the Plan's List of Covered Drugs (Drug List) for HAP CareSource MI Coordinated Health describing covered drugs, restrictions (prior authorization, quantity limits, step therapy), member rights (exceptions, transitions), pharmacy supply options (mail-order, retail), and FAQs. It applies to plan members using network pharmacies and explains rules for Medicare and Michigan Medicaid covered drugs.

    Policy Summary
    PayerCareSource
    PolicyHAP CareSource MI Coordinated Health List of Covered Drugs (Drug List)
    Policy CodePolicy N/A
    Change TypeFormulary update (dates clarified)
    Effective DateApr 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization for drugs flagged PA or B/D PA before dispensing to ensure coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes — this excerpt is an updated segment of the drug list showing update dates (last updated 03/13/2026 and document updated 04/01/2026).

    Document version 9, Formulary ID 00026143; Drug List updated on 04/01/2026; some table portions note last updated 03/13/2026.

    9Document Version

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    00026143
    Formulary ID
    2026-04-01Last Update
    multipleEntries with PA
    multipleEntries with QL
    multipleEntries with NDS/LA

    Coverage Summary

    General coverage / member eligibility

    This Drug List covers medications and certain OTC products available to HAP CareSource MI Coordinated Health members. Covered drugs must be medically necessary, prescribed by a licensed provider, and dispensed at a HAP CareSource network pharmacy. The plan follows Medicare and Michigan Medicaid rules; some products may have special pharmacy network, quantity, prior authorization, step therapy, or other utilization controls. Changes to the Drug List (adds/removals or rule changes) follow federal/state requirements and members may request exceptions or transition supplies when rules change.

    Covered when ALL of the following are met:
    • The drug is prescribed by a licensed provider and deemed medically necessary for the member.
    • HAP CareSource MI Coordinated Health agrees the drug is medically necessary for the member.
    • The prescription is filled at a HAP CareSource MI Coordinated Health network pharmacy.
    • Any required prior authorization, step therapy, quantity limit, or other utilization control specific to the drug has been satisfied.

    Drug List change exceptions / transition supplies

    Transition supplies, formulary change exceptions, and appeals (exceptions) are available to members under Medicare and Medicaid rules. The following criteria groups describe how members and providers can obtain transition supplies, request a formulary exception, and the utilization controls applied per drug.

    title
    type':'criteria_group'
    paragraphs[]

    Exception (appeal) requests

    Members and prescribers may request an exception (also called an appeal) when coverage is denied or a drug is subject to utilization controls. The plan processes exceptions per regulatory timelines and offers expedited reviews when delay would risk health.

    ALL of the following

    • A request for an exception must state why the formulary drug or coverage rule is not suitable and include supporting clinical information.
    • Expedited (urgent) exception requests are available when the prescriber certifies that waiting for a standard decision could seriously harm the member.
    • The plan will notify the member and prescriber of the decision within the timeframes required by Medicare and Michigan Medicaid; approval includes any limits (e.g., quantity, duration).
    • If an exception is denied, members receive notice with reason and instructions for internal appeal and external review rights.

    Utilization Controls by Drug (per-line entries)

    Utilization controls are applied at the drug or formulation level and may include prior authorization, quantity limits, step therapy, age or diagnosis restrictions, refill timing, or specialty pharmacy requirements. The plan enforces these per-line (per product/NDC/formulation) rules as listed on the Drug List.

    title
    type':'criteria_group'
    paragraphs[]

    Per-drug utilization management requirements (listed per product)

    Per-drug utilization management requirements (examples summarized; see the Drug List for each product's specific rules). Each listed product entry includes formulary tier, coverage status, and any of the above utilization controls.

    title
    type':'criteria_group'
    paragraphs[]

    Formulary entry controls

    Formulary entry controls govern how drugs are placed on the Drug List and what utilization restrictions apply when they are listed. Controls include tiering, PA, step edits, quantity limits, and specialty designation.

    title
    type':'criteria_group'
    paragraphs[]

    Formulary entries and utilization controls

    Formulary listings include specific utilization controls for each drug/formulation. The Drug List indicates coverage actions (covered, not covered, PA required, quantity limit, step therapy) and any restrictions by formulation or route.

    title
    type':'criteria_group'
    paragraphs[]

    Formulary listing usage rules (implicit)

    Usage rules and coverage restrictions are applied as implicit policy logic across the Drug List: prescribers must follow documented PA and step therapy processes; pharmacies must adjudicate claims per listed quantity and refill rules.

    title
    type':'criteria_group'
    paragraphs[]

    Coverage actions/limits included in list

    The Drug List includes numerous coverage actions and limits. Examples of coverage actions applied to listed drugs include denial for lack of PA, approval with a specified quantity limit, or coverage contingent on step therapy completion.

    title
    type':'criteria_group'
    paragraphs[]

    Coverage / Restrictions entries (per listed drug/formulation)

    Individual Drug/Formulation coverage and restrictions are listed on the Drug List pages. Each entry includes product name, formulation, coverage status, and any utilization controls or restrictions applicable to that product.

    title
    type':'criteria_group'
    paragraphs[]

    Transition Supplies, Exceptions & Provider Responsibilities

    Note
    Note
    Note
    Note
    Note

    Utilization Controls (PA, QL, ST, NDS, LA, MCD)

    Applicable Codes & NDC Constraints

    List-level abbreviations/flagsmixed
    MOMedication-only / medical benefit flag used in formulary listings
    PAPrior Authorization required flag
    MO (amphotericin b)Amphotericin B formulations flagged as medication-only
    MO (amphotericin b liposome)Amphotericin B liposomal formulation flagged as medication-only
    MO (fluconazole)Fluconazole flagged as medication-only
    Utilization management codesmixed
    PAPrior authorization required
    QLQuantity limit applies
    STStep therapy required
    MOMedication-only (medical administration)
    MO examplesExample drugs commonly carrying UM flags: BIKTARVY (PA/QL), CABENUVA (PA), BARACLUDE (PA/QL), TROGARZO (PA), ODEFSEY (PA), STRIBILD (PA/QL)
    NDC-specific constraintsNDC
    61314*NDC prefix used for select specialty/packaged products (e.g., PYZCHIVA mapping)
    00054*NDC prefix grouping—multiple injectable/oral generics
    00093*NDC prefix grouping—various products
    00781*NDC prefix grouping—injectable/packaged products
    17270*NDC prefix grouping—branded specialty products
    45802*NDC prefix grouping—oral solids/liquids
    60687*NDC prefix grouping—antivirals/antibiotics
    68180*NDC prefix grouping—injectables/oncology agents
    69097*NDC prefix grouping—specialty biologics and injectables
    Examples of drug/table flags (selected covered drugs)mixedCovered
    amphotericin bflagged MO; may require PA for inpatient/outpatient administration
    amphotericin b liposomeflagged MO; high-cost liposomal formulation—PA commonly required
    fluconazoleoften subject to QL for recurring courses
    CRESEMBA ORAL (isavuconazole)antifungal—PA and QL may apply
    itraconazole oral capsuleantifungal—PA/QL possible
    ketoconazole oralsystemic ketoconazole—safety restrictions; PA likely
    BIKTARVYantiretroviral—PA/QL flags common
    CABENUVAlong-acting injectable antiretroviral—PA required
    BARACLUDEantiviral (entecavir)—PA/QL possible
    darunavir (various formulations)antiretroviral—PA/QL depending on formulation
    1–10 of 79
    1/8

    Quick Actions for Clinical/Billing Staff

    Note

    Revision History

    Policy Summary
    PayerCareSource
    PolicyHAP CareSource MI Coordinated Health List of Covered Drugs (Drug List)
    Policy CodePolicy N/A
    Change TypeFormulary update (dates clarified)
    Effective DateApr 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization for drugs flagged PA or B/D PA before dispensing to ensure coverage.
    SourceLink
    On This Page
    Coverage SummaryTransition Supplies, Exceptions & Provider ResponsibilitiesUtilization Controls (PA, QL, ST, NDS, LA, MCD)Applicable Codes & NDC ConstraintsQuick Actions for Clinical/Billing StaffBackground & Document ScopeClinical Evidence & Trial MetricsFrequently Asked QuestionsMedicare / State DeterminationsRevision History